The silencing of HN transcriptional expression via BV.shHN boosted the cytotoxic response of glioma cells with heterogeneous genetic backgrounds, i.e., wtIDH and mIDH glioma cells. The gene discussed is MT-RNR2; the disease is central nervous system cancer.